Consumer News: Your smart TV may be tracking everything you watch—Here’s how to stop it

New data shows nicotine dangers are shifting inside homes

• A new study found nicotine exposures from cigarettes declined in young children, while vape-related incidents rose sharply.

• Researchers reviewed more than 92,000 poison control reports involving children age 5 and younger.

• Unlike cigarettes, many recent vape exposures involved children directly inhaling from devices.

For years, cigarettes were considered one of the biggest nicotine-related hazards for young children at home. But a new study suggests that risk is changing as vaping devices become more common.

Researchers found that while traditional tobacco exposures among young children have been declining, incidents involving e-cigarettes are rising quickly instead.

The concern isnt just that children are getting into nicotine products its how theyre being exposed. Unlike traditional cigarettes, which often involve accidental ingestion or contact, many newer cases linked to e-cigarettes involve children actually inhaling from the devices.

Because many vapes are colorful, compact, and easy to activate, researchers say they may be more accessible and more appealing to curious young children.

"This significant spike in children breathing in these substances tells us the risk has changed: Its no longer just about a toddler swallowing something they found on the floor, researcher Perry Rosen said in a news release. Many recent cases involve children actively using e-cigarette devices after gaining access to them.

How the study worked

Researchers from the New Jersey Poison Control Center analyzed reports from the National Poison Data System, a database that collects poison exposure cases from across the United States.

The team looked specifically at nicotine exposure reports involving children age 5 and younger between 2016 and 2023. In total, the study included more than 92,000 reported exposures.

The researchers compared different types of nicotine products, including conventional tobacco products such as cigarettes, as well as newer products like disposable e-cigarettes and nicotine pouches.

Their goal was to better understand how childrens nicotine exposure risks have changed as the nicotine product landscape has evolved. According to the study, this was the first analysis to examine exposure trends across all nicotine product categories in young children over this time period.

What researchers found

The study found that exposures involving conventional tobacco products dropped by 43% during the study period.

At the same time, incidents involving e-cigarettes increased by 243%. Researchers also found that children exposed to e-cigarettes were more likely to require evaluation at a healthcare facility compared with children exposed to cigarettes.

Researchers noted that existing safety measures, such as child-resistant liquid nicotine containers, may help reduce accidental swallowing but do not address a newer pattern of exposure: children mimicking adults or older family members who vape.

The authors suggest that future safety efforts may need to focus not only on packaging, but also on device-level protections that make products harder for children to use.

Current laws, which focus on child-resistant packaging for nicotine liquids, are no longer enough, said researcher Diane Calello, executive and medical director of the New Jersey Poison Control Center.

This study underscores the need for safety regulations at the device level. For example, manufacturers should be required to include flow restrictors or designs that make it more difficult for a child to activate a device.

The early summer trends that could impact your budget

• Spending isnt dropping: Its being redirected toward basics and home-focused activities, with less going to convenience and extras.

• The best way to save right now is to shop more intentionally:Cook from scratch, plan purchases, and take advantage of sales and cash back.

• Prices on gas and seasonal items are rising early: Buy sooner, combine trips, and expect more spending at home instead of travel.

Summer hasnt officially started yet, but your wallet can already feel it.

New data from Ibotta shows shoppers arent necessarily spending less; theyre just spending differently. Instead of cutting everything, people are shifting money away from convenience and splurges and putting it toward essentials and at-home living.

Heres whats changing and how you can actually use it to save money this summer.

1. Shift your grocery strategy (This is where the biggest savings are)

Shoppers are moving away from convenience foods like frozen meals and pre-made items, and back toward basics like meat, produce, and pantry staples.

Consumers are realizing that convenience comes at a price, and right now, people are trying to stretch every dollar.

What to do:

• Build meals around ingredients, not shortcuts like expensive pre-made/frozen meals.
• Buy larger packs of meat and portion it yourself.
• Stick to a simple weekly meal plan to avoid those impulse buys.

Pro tip: The middle aisles (snacks, cereal, frozen meals) are where budgets quietly blow up. Shop the perimeter first.

2. Expect to spend more at home And plan for it

A lot of people are scaling back travel this summer. Costs are up, and according to the data, nearly a third of shoppers say theyre taking fewer trips.

But heres the catch: that money doesnt just disappear, it tends to shift to other things. More cookouts. More grocery runs. More well just stay in tonight.

What to do:

• Be sure to budget for higher grocery bills, not lower ones.
• Stock up on grilling staples when they go on sale (meat, buns, condiments).
• Plan those low-cost staycation activities ahead of time.

Pro tip: Treat your at-home spending like a trip budget this summer. Its smart to set a weekly cap so those small purchases dont add up fast and ruin your budget.

3. Promotions matter more than ever

Data shows that items on sale are outperforming everything else right now. Shoppers are actively chasing deals and winning because of it.

What to do:

• Stack store sales + coupons + cash back whenever possible.
• Time your purchases around promotions (especially summer staples).
• Use rebate apps to cash in those receipts.

4. Watch where prices are quietly rising

Gas prices are out of control this year, and its forcing people to cut back in other areas, especially on groceries and extras.

Thats why youre seeing fewer impulse buys and more smart shopping.

What to do:

• Combine errands to save on gas.
• Avoid high-traffic gas stations (theyre almost always more expensive).
• Use a gas app like GasBuddy to find cheaper fill-ups.

5. Start summer shopping earlier than usual

Most shoppers miss the fact that summer demand typically starts before summer actually begins.

Were already seeing price spikes in:

• Sunscreen
• Lawn and garden
• Pest control

What to do instead:

• Try to buy seasonal items before peak demand hits.
• Watch for early-season sales instead of waiting until June.
• Stock up gradually when you find a good price instead of panic-buying everything at once.

Experts say better food choices can improve long-term quality of life

• A clinical trial tested whether delivering healthy food helps people recover after heart failure hospitalization.

• The program was highly feasible, with strong participation and satisfaction among patients.

• While it didnt reduce hospital visits, patients reported meaningful improvements in quality of life.

The idea that food can play a role in medical care has been gaining traction but how well does it actually work in real life?

A new clinical trial led by UT Southwestern Medical Center set out to answer that question in people recovering from heart failure, a condition affecting millions of Americans.

After leaving the hospital, many patients face a tough transition. Managing medications, following dietary guidelines, and accessing healthy food can all be challenging especially for those experiencing food insecurity.

Researchers wanted to know whether directly providing nutritious food could help. Their approach sometimes called food as medicine focused on giving patients the tools and resources to eat better during a critical recovery window.

This was designed as a pilot trial to answer a very practical question: Can we actually deliver food-as-medicine interventions to patients in the vulnerable period after a heart failure hospitalization and will patients accept them? researcher Ambarish Pandey, M.D. said in a news release.

What we showed is that this approach is not only feasible, but patients also really valued it.

How the study worked

The trial included 150 patients who had recently been hospitalized for heart failure at two hospitals in Dallas between April 2024 and October 2025. Participants were enrolled within two weeks of discharge and followed for 90 days.

They were randomly assigned to one of three groups: one received medically tailored meals designed by dietitians, another received boxes of fresh produce along with recipes, and a third group received standard care with dietary counseling alone.

Among those receiving food support, researchers also tested whether tying deliveries to behaviors like attending clinic visits or filling prescriptions made a difference.

The study tracked several outcomes, including how consistently food was delivered, how much participants used it, and whether it affected hospital readmissions or emergency department visits. Researchers also measured quality of life using a standardized questionnaire.

What the researchers found

Overall, the program proved highly workable. More than 90% of food deliveries were completed, and about 96% of participants stayed in the study strong indicators that patients were willing and able to engage.

However, when it came to clinical outcomes, the results were more nuanced. Providing food did not significantly reduce hospital readmissions or emergency visits during the 90-day follow-up period.

That said, patients who received food support reported meaningful improvements in their quality of life. Many said they felt better overall, suggesting that access to healthy food may play an important role in day-to-day well-being even if it doesnt immediately change medical outcomes.

Another interesting finding: participants tended to prefer fresh produce boxes over pre-prepared meals, possibly because they allowed for more flexibility and cultural preferences in cooking.

Because this was a relatively short, pilot study, researchers emphasized that larger and longer-term trials are needed. Still, the findings show that food-based interventions can be successfully delivered and that patients value them laying the groundwork for future research.

We are still early in building rigorous evidence for food as medicine, especially in heart failure, Dr. Pandey said. This trial helps establish a foundation for larger, longer-term studies that can test whether these initiatives can ultimately improve clinical outcomes while being delivered in real-world health care settings.

Large U.S. study finds small but notable mortality link

• A large U.S. study found some IBS medications are linked to a higher risk of death over time.

• Antidepressants and certain antidiarrheal drugs showed the strongest associations.

• Researchers stress the overall risk remains small and not cause-and-effect.

For millions of Americans living with irritable bowel syndrome (IBS), daily symptom management often means relying on medication. But a new large-scale study is raising questions about how safe some of those treatments are over the long haul.

Researchers from Cedars-Sinai examined commonly used IBS medications and found that some may be associated with a small but measurable increase in the risk of death. While that might sound alarming, experts emphasize that the overall risk for any one person remains low.

Many patients are diagnosed with IBS at a young age and may remain on medications for years, researcher Ali Rezaie, M.D. said in a news release However, most clinical trials of these medications last less than a year, so we know very little about their long-term safety. This study begins to address that gap.

How the study was conducted

To better understand long-term safety, researchers analyzed nearly two decades of electronic health records from more than 650,000 adults in the United States diagnosed with IBS. This makes it the largest real-world study of its kind.

The team compared patients taking different types of IBS treatments, including FDA-approved medications, antidepressants, antispasmodics, and opioid-based antidiarrheal drugs like loperamide and diphenoxylate.

Using this large dataset, researchers evaluated how these medications were associated with all-cause mortality over time.

Importantly, the study was observational, meaning it looked at patterns in existing data rather than testing medications in a controlled trial. That distinction matters: the findings show associations, not proof that the drugs directly cause harm.

What the researchers found

The results revealed clear differences between medication types. Long-term use of antidepressants was associated with about a 35% higher risk of death compared to non-use. Meanwhile, two commonly used antidiarrheal drugs loperamide and diphenoxylate were linked to roughly double the risk.

On the other hand, several other treatments did not show this association. Antispasmodics and certain FDA-approved IBS medications were not linked to increased mortality risk.

Researchers also noted that the increased risk may be tied to higher rates of serious health issues such as cardiovascular events, falls, or stroke among patients taking certain medications.

IBS patients should not panic, but they do need to understand and weigh the small but meaningful risks when considering long-term treatments, Dr. Rezaie said. Patients should speak with their healthcare provider about the safest and most effective options for managing their symptoms.

Treatment for IBS patients should focus on identifying the underlying causes and using the safest, evidence-based options available rather than relying on a single class of medications for long-term management.